|Articles|March 20, 2020

EMA, HMA Announce COVID-19 Guidance

The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic.

For more information, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Generative AI Transforms Clinical Study Report Development
September 16th 2025
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
September 16th 2025
Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares
September 16th 2025
Operational Strategies That Strengthened the NIMBLE Trial Design
September 16th 2025
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
September 15th 2025
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
September 15th 2025

EMA, HMA Announce COVID-19 Guidance

Newsletter

Related Articles

Trending on Applied Clinical Trials Online

Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome

Generative AI Transforms Clinical Study Report Development

Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success

Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares